eHSP90α in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations in advanced lung adenocarcinoma

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: eHSP90α in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations in advanced lung adenocarcinoma ; volume:24 ; number:1 ; day:12 ; month:7 ; year:2024 ; pages:1-13 ; date:12.2024
BMC cancer ; 24, Heft 1 (12.7.2024), 1-13, 12.2024

Creator: Bian, Yingzhen
Liu, Haizhou
Huang, Jinglei
Feng, Zhaorong
Lin, Yanyan
Li, Jilin
Zhang, Litu

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12885-024-12573-3

URN: urn:nbn:de:101:1-2409292113427.778280355864

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bian, Yingzhen
Liu, Haizhou
Huang, Jinglei
Feng, Zhaorong
Lin, Yanyan
Li, Jilin
Zhang, Litu
SpringerLink (Online service)

Other Objects (12)

Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma

Detection of internal exon deletion with exon Del

Aufsatzsammlung

EGFR exon 20 insertion mutations in NSCLC

Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21

CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion

Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy

Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study

Sunvozertinib overcoming resistance to afatinib and osimertinib in lung adenocarcinoma harboring an EGFR exon 18 DelE709_T710insD mutation

Hochschulschrift

Vergleich Gastrointestinaler Stromatumoren (GIST) mit Exon-11-Punktmutationen und Exon-11-Deletionen nach klinisch-pathologischen Parametern und Lokalisation

Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer

Exons deletion of CNKSR2 gene identified in X-linked syndromic intellectual disability

Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma

Detection of internal exon deletion with exon Del

Aufsatzsammlung

EGFR exon 20 insertion mutations in NSCLC

Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21

CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion

Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy

Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study

Sunvozertinib overcoming resistance to afatinib and osimertinib in lung adenocarcinoma harboring an EGFR exon 18 DelE709_T710insD mutation

Hochschulschrift

Vergleich Gastrointestinaler Stromatumoren (GIST) mit Exon-11-Punktmutationen und Exon-11-Deletionen nach klinisch-pathologischen Parametern und Lokalisation

Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer

Exons deletion of CNKSR2 gene identified in X-linked syndromic intellectual disability

Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma

Detection of internal exon deletion with exon Del

Aufsatzsammlung

EGFR exon 20 insertion mutations in NSCLC

Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21

CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion

Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy

Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study

Sunvozertinib overcoming resistance to afatinib and osimertinib in lung adenocarcinoma harboring an EGFR exon 18 DelE709_T710insD mutation

Hochschulschrift

Vergleich Gastrointestinaler Stromatumoren (GIST) mit Exon-11-Punktmutationen und Exon-11-Deletionen nach klinisch-pathologischen Parametern und Lokalisation

Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer

Exons deletion of CNKSR2 gene identified in X-linked syndromic intellectual disability

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

eHSP90α in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations in advanced lung adenocarcinoma

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma

Detection of internal exon deletion with exon Del

EGFR exon 20 insertion mutations in NSCLC

Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21

CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion

Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy

Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study

Sunvozertinib overcoming resistance to afatinib and osimertinib in lung adenocarcinoma harboring an EGFR exon 18 DelE709_T710insD mutation

Vergleich Gastrointestinaler Stromatumoren (GIST) mit Exon-11-Punktmutationen und Exon-11-Deletionen nach klinisch-pathologischen Parametern und Lokalisation

Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer

Exons deletion of CNKSR2 gene identified in X-linked syndromic intellectual disability

Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma

Detection of internal exon deletion with exon Del

EGFR exon 20 insertion mutations in NSCLC

Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21

CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion

Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy

Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study

Sunvozertinib overcoming resistance to afatinib and osimertinib in lung adenocarcinoma harboring an EGFR exon 18 DelE709_T710insD mutation

Vergleich Gastrointestinaler Stromatumoren (GIST) mit Exon-11-Punktmutationen und Exon-11-Deletionen nach klinisch-pathologischen Parametern und Lokalisation

Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer

Exons deletion of CNKSR2 gene identified in X-linked syndromic intellectual disability

Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma

Detection of internal exon deletion with exon Del

EGFR exon 20 insertion mutations in NSCLC

Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21

CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion

Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy

Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study

Sunvozertinib overcoming resistance to afatinib and osimertinib in lung adenocarcinoma harboring an EGFR exon 18 DelE709_T710insD mutation

Vergleich Gastrointestinaler Stromatumoren (GIST) mit Exon-11-Punktmutationen und Exon-11-Deletionen nach klinisch-pathologischen Parametern und Lokalisation

Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer

Exons deletion of CNKSR2 gene identified in X-linked syndromic intellectual disability

Related objects

Reset password